Baird Financial Group’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Baird Financial Group's RGEN Position: Q2 2026 in Review
Baird Financial Group reduced its Repligen (RGEN) stake by 16% in Q2 2026, selling an estimated $3.32M and leaving 144,571 shares worth $19.7M. The position accounts for 0.03% of the portfolio, ranked #405.
Baird Financial Group first reported a position in RGEN in Q2 2020 and has held it in 25 quarters since. The position peaked at $100M in Q3 2021. 480 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Baird Financial Group held 144,571 shares of Repligen worth $19.7M as of Q2 2026.
- Baird Financial Group sold 27,059 Repligen shares in Q2 2026, an estimated $3.32M.
- Repligen made up 0.03% of Baird Financial Group's portfolio in Q2 2026, its #405 holding.
- Baird Financial Group first reported a position in Repligen in Q2 2020 and has held it in 25 quarters since.
- Baird Financial Group's Repligen position peaked at $100M in Q3 2021.
- 480 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.